Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T-cell Non-Hodgkin Lymphoma”

2,332 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,332 results

Early research (Phase 1)Ended earlyNCT00058773
What this trial is testing

Giving Gene Marked EBV Specific T-Cells to Patients Receiving a BMT for Relapsed EBV-Positive Hodgkin Disease

Who this might be right for
Hodgkin DiseaseNon-Hodgkins Lymphoma
Baylor College of Medicine 5
Early research (Phase 1)Not Yet RecruitingNCT06712173
What this trial is testing

Linperlisib Combined With EZH2 Inhibitor in Relapsed/Refractory Peripheral T-cell Lymphoma (PTCL)

Who this might be right for
Peripheral T Cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 33
Testing effectiveness (Phase 2)Ended earlyNCT01746173
What this trial is testing

CHOEP + High Dose Therapy + Auto SCT for T-Cell Lymphoma

Who this might be right for
T-cell Non-Hodgkin Lymphoma
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)UnknownNCT06149169
What this trial is testing

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinDiffuse Large B Cell Lymphoma
Shanghai Ming Ju Biotechnology Co., Ltd. 10
Early research (Phase 1)Active Not RecruitingNCT03233854
What this trial is testing

CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells With or Without NKTR-255 in Adults With Recurrent or Refractory B Cell Malignancies

Who this might be right for
B Acute Lymphoblastic LeukemiaCD19 PositiveMinimal Residual Disease+1 more
Stanford University 56
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07477366
What this trial is testing

Study of CD19 t-haNK and NAI With Rituximab in Participants With Indolent Non-Hodgkin Lymphoma

Who this might be right for
Relapsed B-Cell Non-Hodgkin Lymphoma
ImmunityBio, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00506129
What this trial is testing

Allogeneic Transplantation in Patients With Cutaneous T-Cell Lymphoma

Who this might be right for
LymphomaDisorder Related to Bone Marrow Transplantation
M.D. Anderson Cancer Center 33
Not applicableUnknownNCT02039895
What this trial is testing

Helical Irradiation of Total Skin (HITS) for Cutaneous Lymphoma

Who this might be right for
Cutaneous T-cell Lymphoma
Far Eastern Memorial Hospital 10
Testing effectiveness (Phase 2)Study completedNCT03192202
What this trial is testing

AFM13 in Relapsed/Refractory Cutaneous Lymphomas

Who this might be right for
Lymphoma, T-Cell, Cutaneous
Ahmed Sawas 18
Early research (Phase 1)UnknownNCT04004637
What this trial is testing

CD7 CAR-T Cells for Patients With R/R CD7+ NK/T Cell Lymphoma,T-lymphoblastic Lymphoma and Acute Lymphocytic Leukemia

Who this might be right for
T-lymphoblastic LymphomaNK/T Cell LymphomaAcute Lymphocytic Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Early research (Phase 1)Ended earlyNCT00369629
What this trial is testing

Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome

Who this might be right for
Lymphoma
Northwestern University 14
Large-scale testing (Phase 3)Enrolling By InvitationNCT05678933
What this trial is testing

AC-CHOP Versus CHOP in Patients With Previously Untreated PTCL-TFH

Who this might be right for
Peripheral T-cell Lymphoma Targeted Therapy
Tianjin Medical University Cancer Institute and Hospital 200
Early research (Phase 1)Active Not RecruitingNCT05784441
What this trial is testing

JNJ-90009530 in Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma (r/r B-NHL)

Who this might be right for
Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
Janssen Research & Development, LLC 21
Not applicableUnknownNCT03884205
What this trial is testing

GDPE/CEOPE Compared With CEOPE for Newly Diagnosed Patients With PTCL

Who this might be right for
PTCLGemcitabine
Shandong Provincial Hospital 120
Post-approval studies (Phase 4)UnknownNCT03150602
What this trial is testing

A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy

Who this might be right for
Peripheral T Cell LymphomaProgression, Disease
Taiwan Mundipharma Pharmaceuticals Ltd. 22
Early research (Phase 1)WithdrawnNCT02875002
What this trial is testing

Study of Volasertib and Belinostat in Patients With Relapsed and Refractory Aggressive B-cell and T-cell Lymphomas

Who this might be right for
Relapsed and Refractory Aggressive B- and T-cell LymphomasLymphoma
Yale University
Early research (Phase 1)Study completedNCT00355472
What this trial is testing

Phase I Study of KW-0761 in Relapsed Patients With CCR4-Positive ATL and PTCL

Who this might be right for
Adult T-Cell Leukemia and Lymphoma (ATL)Adult Peripheral T-Cell Lymphoma (PTCL)
Kyowa Kirin Co., Ltd. 16
Testing effectiveness (Phase 2)Study completedNCT04004572
What this trial is testing

Sintilimab, Pegaspargase and Anlotinib for Stage IV Natural Killer /T-cell Lymphoma

Who this might be right for
Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type
Rong Tao 37
Testing effectiveness (Phase 2)Ended earlyNCT00365274
What this trial is testing

SGN-30 and Combination Chemotherapy in Treating Patients With Newly Diagnosed Anaplastic Large Cell Lymphoma

Who this might be right for
Anaplastic Large Cell Lymphoma
National Cancer Institute (NCI) 6
Testing effectiveness (Phase 2)Study completedNCT00156013
What this trial is testing

Clofarabine for Relapsed or Refractory T-Cell or B-Cell Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Lymphoma, B-CellLymphoma, Non-Hodgkin
Oncology Specialists, S.C. 33
Next Page